Newest Immunotherapies for Blood Cancer! What to Know about Bispecifics & CAR T-Cell Therapy

Поделиться
HTML-код
  • Опубликовано: 8 фев 2025

Комментарии • 5

  • @ThePatientStory
    @ThePatientStory  2 года назад

    What was the biggest lesson you learned in your own cancer diagnosis? Leave us a comment below 👇

  • @Boiler690Waldron
    @Boiler690Waldron Год назад +1

    Proud to have Dr. Usmani as my guide through the Myleoma journey. A great person who takes the time to get to know you as a patient and explain the science at a level that one can understand.

  • @michelles9897
    @michelles9897 2 года назад

    Thank you Cindy and Dr. Usmani.

  • @webversation
    @webversation Год назад

    Fast CarT on China presentation apparently has shown 100% success! Would be nice to learn from them too perhaps!

  • @Rene-uz3eb
    @Rene-uz3eb 2 года назад

    Personal opinion is myeloma may be the only cancer I can think of where targeted cell destruction makes sense, because these B clones wreak havoc overproducing antibodies. But the way I read it this destroys all B clones,not just the proliferating clone, so side effect immuno compromised during effective period. Also only works while therapy is given. I think better to target the reason why the B cells are going into survival mode. Hopefully this has nothing to do with radiation damage to the bone marrow like in leukemia, but afaik the B cells still work against infection except for that one clone family so probably just cancer program switched on due to too much iron in some spine locations.